Clotting Factor Concentrates and Other Biological Products Bill 2012

Public bill · Government · Presented

Responsibility for buying Ireland’s national supply of clotting factor concentrates and other biological medicines, including recombinant protein treatments, would move from the Irish Blood Transfusion Service to St James’s Hospital. These medicines are used to treat haemophilia and other inherited or acquired disorders affecting blood clotting.

Formal long title

Bill entitled an Act to provide for the procurement and making available of clotting factor concentrates and other biological medicinal products, including recombinant protein preparations, for the purpose of treating coagulation and other disorders and to provide for related matters

Last updated 12 April 2018